Provided by Tiger Trade Technology Pte. Ltd.

Super League Gaming Inc.

3.73
-0.1700-4.36%
Post-market: 3.760.0300+0.80%19:10 EDT
Volume:105.42K
Turnover:396.64K
Market Cap:9.23M
PE:-0.30
High:3.88
Open:3.75
Low:3.71
Close:3.90
52wk High:137.16
52wk Low:2.12
Shares:2.47M
Float Shares:2.02M
Volume Ratio:0.50
T/O Rate:5.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.3857
EPS(LYR):-40.4307
ROE:-503.98%
ROA:-64.67%
PB:0.71
PE(LYR):-0.09

Loading ...

Super League FY2025 net loss widens 24.51% to $20.7 million; revenue drops 29.91% to $11.3 million

Reuters
·
Mar 27

Press Release: Super League Reports Fourth Quarter and Full Year 2025 Financial Results, Completes Business Transformation and Advances Path to Profitability

Dow Jones
·
Mar 27

Super League Enterprise Inc expected to post a loss of $3.28 a share - Earnings Preview

Reuters
·
Mar 25

Super League to buy Misfits Ads Division for USD 1.5 million and 19.99% equity stake

Reuters
·
Mar 21

Press Release: Alumis Reports Year End 2025 Financial Results and Highlights Recent Achievements

Dow Jones
·
Mar 20

Super League to acquire Misfits Ads Division for USD 1.5 million and 19.99% equity stake

Reuters
·
Mar 18

BRIEF-Super League Signs Definitive Agreement To Acquire Misfits ADS Division, Expanding Revenue And Accelerating Path To Positive Adjusted EBITDA

Reuters
·
Mar 18

Super League Enterprise Inc - to Buy Misfits Ads Division From Misfits Gaming Group

THOMSON REUTERS
·
Mar 18

Super League Signs Definitive Agreement to Acquire Misfits Ads Division, Expanding Revenue and Accelerating Path to Positive Adjusted Ebitda

THOMSON REUTERS
·
Mar 18

Super League Enterprise Inc. updates financial calendar with Q4 and full-year 2025 earnings webinar

Reuters
·
Mar 18

Press Release: Zenas BioPharma Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Dow Jones
·
Mar 16

Press Release: Artiva Biotherapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights

Dow Jones
·
Mar 11

Cullinan Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results

GlobeNewswire
·
Mar 10